Synopsis:This small, prospective case series evaluated pregnancy outcomes of women who took levodopa, pramipexole, ropinirole, and rotigotine for treatment of restless legs syndrome during pregnancy. No major birth defects were identified with any of the treatments.
Source: Dostal M, et al. Pregnancy outcome following use of levodopa, pramipexole, ropinerole, and rotigotine for restless legs syndrome during pregnancy: A case series. Eur J Neurol 2013;20:1241-1246.